Works by Brodowicz, Thomas

Results: 57
    1
    2
    3
    4
    5
    6

    Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.

    Published in:
    BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-981
    By:
    • Lamm, Wolfgang;
    • Natter, Camilla;
    • Schur, Sophie;
    • Köstler, Wolfgang J.;
    • Reinthaller, Alexander;
    • Krainer, Michael;
    • Grimm, Christoph;
    • Horvath, Reinhard;
    • Amann, Gabriele;
    • Funovics, Philipp;
    • Brodowicz, Thomas;
    • Polterauer, Stephan
    Publication type:
    Article
    7
    8
    9
    10
    11

    REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis.

    Published in:
    2017
    By:
    • Berry, Vincent;
    • Basson, Laurent;
    • Bogart, Emilie;
    • Mir, Olivier;
    • Blay, Jean‐Yves;
    • Italiano, Antoine;
    • Bertucci, François;
    • Chevreau, Christine;
    • Clisant‐Delaine, Stéphanie;
    • Liegl‐Antzager, Bernadette;
    • Tresch‐Bruneel, Emmanuelle;
    • Wallet, Jennifer;
    • Taieb, Sophie;
    • Decoupigny, Emilie;
    • Cesne, Axel;
    • Brodowicz, Thomas;
    • Penel, Nicolas;
    • Blay, Jean-Yves;
    • Bertucci, François;
    • Clisant-Delaine, Stéphanie
    Publication type:
    journal article
    12
    13
    14
    15

    Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three Trials.

    Published in:
    Oncology, 2012, v. 83, n. 5, p. 241, doi. 10.1159/000339534
    By:
    • Modest, Dominik P.;
    • Brodowicz, Thomas;
    • Stintzing, Sebastian;
    • Jung, Andreas;
    • Neumann, Jens;
    • Laubender, Ruediger P.;
    • Ocvirk, Janja;
    • Kurteva, Galina;
    • Papai, Zsuzsanna;
    • Knittelfelder, Regina;
    • Kirchner, Thomas;
    • Heinemann, Volker;
    • Zielinski, Christoph C.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    The efficacy of trastuzumab in Her-2/ neu-overexpressing metastatic breast cancer is independent of p53 status.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2005, v. 131, n. 7, p. 420, doi. 10.1007/s00432-005-0670-3
    By:
    • Köstler, Wolfgang;
    • Brodowicz, Thomas;
    • Hudelist, Gernot;
    • Rudas, Margaretha;
    • Horvat, Reinhard;
    • Steger, Günther;
    • Singer, Christian;
    • Attems, Johannes;
    • Rabitsch, Werner;
    • Fakhrai, Negar;
    • Elandt, Katarzyna;
    • Wiltschke, Christoph;
    • Hejna, Michael;
    • Zielinski, Christoph
    Publication type:
    Article
    28
    29
    30
    31

    Geriatric Assessment of Older Patients Receiving Trabectedin in First-Line Treatment for Advanced Soft Tissue Sarcomas: The E-TRAB Study from The German Interdisciplinary Sarcoma Group (GISG-13).

    Published in:
    Cancers, 2024, v. 16, n. 3, p. 558, doi. 10.3390/cancers16030558
    By:
    • Kasper, Bernd;
    • Pink, Daniel;
    • Rothermundt, Christian;
    • Richter, Stephan;
    • Augustin, Marinela;
    • Kollar, Attila;
    • Kunitz, Annegret;
    • Eisterer, Wolfgang;
    • Gaidzik, Verena;
    • Brodowicz, Thomas;
    • Egerer, Gerlinde;
    • Reichardt, Peter;
    • Hohenberger, Peter;
    • Schuler, Markus K.
    Publication type:
    Article
    32

    Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient ® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06).

    Published in:
    Cancers, 2021, v. 13, n. 6, p. 1223, doi. 10.3390/cancers13061223
    By:
    • Pink, Daniel;
    • Andreou, Dimosthenis;
    • Bauer, Sebastian;
    • Brodowicz, Thomas;
    • Kasper, Bernd;
    • Reichardt, Peter;
    • Richter, Stephan;
    • Lindner, Lars H.;
    • Szkandera, Joanna;
    • Grünwald, Viktor;
    • Kebenko, Maxim;
    • Kirchner, Marietta;
    • Hohenberger, Peter;
    • D'Incalci, Maurizio;
    • Milhem, Mohammed M.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39

    Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease.

    Published in:
    Wiener Klinische Wochenschrift, 2013, v. 125, n. 15/16, p. 439, doi. 10.1007/s00508-013-0385-4
    By:
    • Anghel, Rodica;
    • Bachmann, Alexander;
    • Bekşac, Meral;
    • Brodowicz, Thomas;
    • Finek, Jindřich;
    • Komadina, Radko;
    • Krzemieniecki, Krzysztof;
    • Lang, Istvan;
    • Marencak, Jozef;
    • Moos, Roger;
    • Pecherstorfer, Martin;
    • Rordorf, Tamara;
    • Vrbanec, Damir;
    • Zielinski, Christoph
    Publication type:
    Article
    40
    41

    Konsensus Diagnose und Therapie von Weichteilsarkomen.

    Published in:
    Wiener Klinische Wochenschrift, 2012, v. 124, n. 3/4, p. 85, doi. 10.1007/s00508-011-0079-8
    By:
    • Brodowicz, Thomas;
    • Amann, Gabriele;
    • Leithner, Andreas;
    • Sztankay, Arpad;
    • Kainberger, Franz;
    • Eisterer, Wolfgang;
    • Liegl-Atzwanger, Bernadette;
    • Rachbauer, Franz;
    • Rath, Thomas;
    • Bergmann, Michael;
    • Funovics, Philipp T.;
    • Ploner, Ferdinand;
    • Windhager, Reinhard
    Publication type:
    Article
    42

    Intensified adjuvant IFADIC chemotherapy in combination with radiotherapy versus radiotherapy alone for soft tissue sarcoma: long-term follow-up of a prospective randomized feasibility trial.

    Published in:
    Wiener Klinische Wochenschrift, 2010, v. 122, n. 21/22, p. 614, doi. 10.1007/s00508-010-1472-4
    By:
    • Fakhrai, Negar;
    • Ebm, Claudia;
    • Kostler, Wolfgang J.;
    • Jantsch, Marion;
    • Abdolvahab, Farshid;
    • Dominkus, Martin;
    • Pokrajac, Boris;
    • Kauer-Dorner, Daniela;
    • Zielinski, Christoph C.;
    • Brodowicz, Thomas
    Publication type:
    Article
    43
    44

    Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)

    Published in:
    Breast Cancer Research & Treatment, 2010, v. 119, n. 1, p. 169, doi. 10.1007/s10549-009-0553-4
    By:
    • Tomova, Antoaneta;
    • Bartsch, Rupert;
    • Brodowicz, Thomas;
    • Tzekova, Valentina;
    • Timcheva, Constanta;
    • Wiltschke, Christoph;
    • Gerges, Dany;
    • Pawlega, Jan;
    • Spanik, Stanislav;
    • Inbar, Moshe;
    • Zielinski, Christoph
    Publication type:
    Article
    45

    Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG).

    Published in:
    Breast Cancer Research & Treatment, 2008, v. 112, n. 3, p. 557, doi. 10.1007/s10549-008-9894-7
    By:
    • Kahán, Zsuzsanna;
    • Spanik, Stanislav;
    • Wagnerova, Maria;
    • Skacel, Tomas;
    • Planko, Barbara;
    • Fitzthum, Elisabeth;
    • Lindner, Elisabeth;
    • Soldatenkova, Victoria;
    • Zielinski, Christoph;
    • Brodowicz, Thomas
    Publication type:
    Article
    46
    47
    48

    FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS an Status: Updated Analysis of the CECOG/CORE 1.2.002 Study.

    Published in:
    Clinical Colorectal Cancer, 2015, v. 14, n. 2, p. 91, doi. 10.1016/j.clcc.2014.12.003
    By:
    • Kaczirek, Klaus;
    • Ciuleanu, Tudor E.;
    • Vrbanec, Damir;
    • Marton, Erika;
    • Messinger, Diethelm;
    • Liegl-Atzwanger, Bernadette;
    • Wrba, Fritz;
    • Knittelfelder, Regina;
    • Lindner, Elisabeth;
    • Zielinski, Christoph C.;
    • Streubel, Berthold;
    • Brodowicz, Thomas
    Publication type:
    Article
    49
    50